Drug intelligence / Profile preview

polymyxin b sulfate + lidocaine hydrochloride + bacitracin zinc + neomycin

Development stage
Approved
Lead developer
Kenvue
Modality
Peptides, Small Molecules
Administration
Topical
01

Overview

**Polymyxin b sulfate + lidocaine hydrochloride + bacitracin zinc + neomycin** is a fixed-dose topical first-aid combination of three antibacterial agents and the local anesthetic lidocaine. Bacitracin inhibits bacterial cell-wall precursor recycling through binding to undecaprenyl pyrophosphate; neomycin is an aminoglycoside that impairs bacterial protein synthesis through the 30S ribosomal subunit; and polymyxin B disrupts susceptible Gram-negative bacterial outer membranes by binding lipopolysaccharide. Lidocaine reversibly blocks voltage-gated sodium channels to provide local analgesia. The combination is supplied as an OTC ointment for prevention of infection and temporary relief of pain or discomfort in minor cuts, scrapes, and burns. It is not a treatment for painful urethritis; that indication applies to lidocaine hydrochloride jelly products rather than this four-component topical antibiotic formulation.

Brand names
Neosporin Plus LidocaineTriple Antibiotic Plus Lidocaine
Other names
neomycin and polymyxin B sulfates + bacitracin zinc + lidocaine ointmenttriple antibiotic plus lidocaine ointment
02

Targets

NaV (Voltage-gated sodium channels)C55-PP (Undecaprenyl pyrophosphate)Lipid A phosphate (Lipid A phosphate groups)30S A-site (Bacterial ribosomal 30S A-site)

Beyond the preview

Go deeper on polymyxin b sulfate + lidocaine hydrochloride + bacitracin zinc + neomycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polymyxin b sulfate + lidocaine hydrochloride + bacitracin zinc + neomycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call